André-Michel joined ArchiMed in 2018. He has over 30 years of experience in the Healthcare sector, through CEO and non-executive Director positions within European and US Medtech leaders such as LivaNova (formed through the merger of Cyberonics and Sorin Group), Edwards Lifesciences and Baxter.
Over the course of his career, André-Michel has overseen the integration of over 15 acquisitions and has successfully led the IPOs of three companies as either CEO or as a Board Member.
André-Michel is a member of the Institut Montaigne, and has also founded the professional association « MedTech in France ».
André-Michel graduated with an MSc in Chemical Engineering from Centrale Lille, and holds an MBA from INSEAD. He speaks fluent English and Italian.